Literature DB >> 8941324

Characterization of the protein product encoded by a splicing variant of the Marek's disease virus Eco-Q gene (Meq).

Q Peng1, Y Shirazi.   

Abstract

In the present study, we report the characterization of a 212-amino-acid polypeptide encoded by a splicing variant of the Marek's disease virus Eco-Q gene (Meq). This protein, referred to as Meq-sp, contains the N-terminal 100 amino acids of Meq, which include part of Meq's DNA binding/dimerization domain, but lacks the transactivation domain of Meq. Thus, Meq-sp was examined for its ability to bind to DNA and act as a transactivator. Results indicated that while Meq and Meq-sp could both bind to the AP-1 binding site, the 110 C-terminal amino acid residues of Meq-sp lacked the ability to function as a transactivator when fused to the GAL4 (1-147) DNA binding motif. To investigate whether Meq-sp can interact with Meq or with c-jun, protein-protein and protein-DNA interactions in vitro were examined. Results showed that Meq-sp can associate with both Meq and c-jun and bind to the AP-1 site with a higher affinity as a heterodimer with c-jun. These results suggest that Meq-sp could compete with Meq for heterodimer formation with c-jun and dimer binding to DNA and possibly act as a transdominant negative regulator of Meq activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8941324     DOI: 10.1006/viro.1996.0629

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys.

Authors:  T Yamaguchi; S L Kaplan; P Wakenell; K A Schat
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Nuclear localization and dynamic properties of the Marek's disease virus oncogene products Meq and Meq/vIL8.

Authors:  Jonathan M Anobile; Vaithilingaraja Arumugaswami; Danielle Downs; Kirk Czymmek; Mark Parcells; Carl J Schmidt
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript.

Authors:  Joan Burnside; Erin Bernberg; Amy Anderson; Cheng Lu; Blake C Meyers; Pamela J Green; Neeta Jain; Grace Isaacs; Robin W Morgan
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.

Authors:  E Le Rouzic; P Thoraval; M Afanassieff; Y Cherel; G Dambrine; B Perbal
Journal:  Mol Pathol       Date:  2002-08

5.  MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs.

Authors:  Yongxiu Yao; Yuguang Zhao; Hongtao Xu; Lorraine P Smith; Charles H Lawrie; Michael Watson; Venugopal Nair
Journal:  J Virol       Date:  2008-02-06       Impact factor: 5.103

6.  Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1.

Authors:  Stephen J Spatz; Robert F Silva
Journal:  Virus Genes       Date:  2006-09-09       Impact factor: 2.198

7.  Comparative analysis of oncogenic genes revealed unique evolutionary features of field Marek's disease virus prevalent in recent years in China.

Authors:  Mingxing Tian; Yang Zhao; Yan Lin; Nianli Zou; Cheng Liu; Ping Liu; Sanjie Cao; Xintian Wen; Yong Huang
Journal:  Virol J       Date:  2011-03-15       Impact factor: 4.099

8.  Pervasive Differential Splicing in Marek's Disease Virus can Discriminate CVI-988 Vaccine Strain from RB-1B Very Virulent Strain in Chicken Embryonic Fibroblasts.

Authors:  Yashar Sadigh; Abdessamad Tahiri-Alaoui; Stephen Spatz; Venugopal Nair; Paolo Ribeca
Journal:  Viruses       Date:  2020-03-18       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.